Researchers identified patients with ulcerative colitis and Crohn’s disease undergoing colonoscopic surveillance between January 2000 and November 2013.
Researchers found that 440 colonoscopies in 401 patients were performed using chromoendoscopy and 1,802 colonoscopies in 772 patients were performed using WLE. Dysplasia was detected during 48 surveillance procedures in the chromoendoscopy group as compared with 189 procedures in the WLE group. Targeted biopsies showed 59 dysplastic lesions in the chromoendoscopy group, whereas 211 dysplastic lesions were detected in the WLE group using targeted biopsies.
More articles on GI/endoscopy:
How physician report cards improve colonoscopy quality: 4 things to know
Olympus alerted European hospitals of scope infection risk 2 years ago
Boston Scientific price target bumped up to $20
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
